Early Vascular Cells Improve Microvascularization Within 3D Cardiac Spheroids

Abstract

Introduction:

A key obstacle in the creation of engineered cardiac tissues of clinically relevant sizes is limited diffusion of oxygen and nutrients. Thus, there is a need for organized vascularization within a three-dimensional (3D) tissue environment. Human induced pluripotent stem cell (hiPSC)-derived early vascular cells (EVCs) have shown to improve organization of vascular networks within hydrogels. We hypothesize that introduction of EVCs into 3D microtissue spheroids will lead to increased microvascular formation and improve spheroid formation.

Methods:

HiPSC-derived cardiomyocytes (CMs) were cocultured with human adult ventricular cardiac fibroblasts (FB) and either human umbilical vein endothelial cells (HUVECs) or hiPSC-derived EVCs for 72 h to form mixed cell spheroids. Three different groups of cell ratios were tested: Group 1 (control) consisted of CM:FB:HUVEC 70:15:15, Group 2 consisted of CM:FB:EVC 70:15:15, and Group 3 consisted of CM:FB:EVC 40:15:45. Vascularization, cell distribution, and cardiac function were investigated.

Results:

Improved microvasculature was found in EVC spheroids with new morphologies of endothelial organization not found in Group 1 spheroids. CMs were found in a core-shell type distribution in Group 1 spheroids, but more uniformly distributed in EVC spheroids. Contraction rate increased into Group 2 spheroids compared to Group 1 spheroids.

Conclusion:

The triculture of CM, FB, and EVC within a multicellular cardiac spheroid promotes microvascular formation and cardiac spheroid contraction.

Impact statement

A key obstacle in the creation of cardiac tissues of clinically relevant sizes is the establishment of microvascular networks to support tissue survival and growth. Thus, there is a need for organized vascularization within a three-dimensional (3D) tissue environment. This study demonstrates a method of using early vascular cells (EVCs) to create 3D cardiac spheroids with increased microvascular formation. These vascularized spheroids can then be used as building blocks to create larger vascularized cardiac constructs. This study also serves to demonstrate the ability of EVCs to balance increased vascularization with maintained cardiac function at specific cell ratios within cardiac spheroids.